drugset / Trial / NCT00941278

An Efficacy and Safety Study of PH-10 Aqueous Hydrogel for the Treatment of Plaque Psoriasis

NCT00941278

Phase 2 Completed 30 enrolled Provectus Pharmaceuticals
Non-randomizedSingle-groupOpen-labelTreatment

Summary

PH-10 is an aqueous hydrogel formulation of rose bengal disodium (RB) for topical administration to the skin, and is being studied for the treatment of cutaneous skin disorders, specifically psoriasis and atopic dermatitis. This phase 2 efficacy and safety study will assess topical PH-10 applied once daily to areas of mild to moderate plaque psoriasis.

Timeline

Start
2009-07
Primary completion
2009-12
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject rose bengal disodium Unknown 0.001 % Topical

Indications